Evidence map›Paper›PMID 42199985›Full record

ArticleACS applied nano materials2026

Indirect Laser-Mediated Halogenation of Graphene: Implications for Hydrogen Evolution Reaction.

Farheen Khurshid, Jeyavelan Muthu, Jan Plšek, Martin Kalbáč

Abstract read
In one paragraph

Article in ACS applied nano materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Farheen KhurshidDepartment of Low-Dimensional Systems, J. Heyrovsky Institute of Physical Chemistry, Prague 18200, Czech Republic.ORCID https://orcid.org/0000-0002-1371-6150
Jeyavelan MuthuDepartment of Low-Dimensional Systems, J. Heyrovsky Institute of Physical Chemistry, Prague 18200, Czech Republic.ORCID https://orcid.org/0000-0001-7715-3628
Jan PlšekDepartment of Low-Dimensional Systems, J. Heyrovsky Institute of Physical Chemistry, Prague 18200, Czech Republic.
Martin KalbáčDepartment of Low-Dimensional Systems, J. Heyrovsky Institute of Physical Chemistry, Prague 18200, Czech Republic.ORCID https://orcid.org/0000-0001-9574-4368

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laser-assisted functionalization has emerged as a versatile route for patterning and chemical modification of two-dimensional (2D) materials, particularly graphene. However, conventional direct laser processing often induces severe photothermal damage, generating lattice defects that compromise charge transport and limit performance in applications such as electrocatalysis, sensing, and optoelectronics. We present an indirect laser-assisted functionalization strategy that prevents lattice defect formation while allowing covalent halogenation of graphene. N-chlorosuccinimide (NCS) and N-bromosuccinimide (NBS) precursors are selectively irradiated with a 455 nm pulsed laser, generating reactive halogen radicals that diffuse toward the graphene surface and form covalent functionalization without direct exposure of the graphene lattice to the laser. Raman and X-ray photoelectron spectroscopy confirm efficient covalent halogenation. The preserved graphene framework maintains high carrier mobility while introducing catalytically active sites, yielding a 2-fold reduction in overpotential and Tafel slope for the hydrogen evolution reaction compared to pristine graphene. This indirect, radical-mediated pathway provides a generalizable framework for laser-driven, defect-controlled functionalization of graphene and other 2D materials.

Indexed as

covalent functionalizationdefectsgraphenehalogenationpulsed-laser

Identifiers

PMID42199985
PMCPMC13200163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.